Stuart E. Starr

8.7k total citations
140 papers, 6.5k citations indexed

About

Stuart E. Starr is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Stuart E. Starr has authored 140 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Epidemiology, 54 papers in Immunology and 36 papers in Virology. Recurrent topics in Stuart E. Starr's work include Cytomegalovirus and herpesvirus research (62 papers), Herpesvirus Infections and Treatments (53 papers) and Immune Cell Function and Interaction (34 papers). Stuart E. Starr is often cited by papers focused on Cytomegalovirus and herpesvirus research (62 papers), Herpesvirus Infections and Treatments (53 papers) and Immune Cell Function and Interaction (34 papers). Stuart E. Starr collaborates with scholars based in United States, France and Hungary. Stuart E. Starr's co-authors include Stanley A. Plotkin, Giorgio Trinchieri, B Perussia, André J. Nahmias, Allan M. Arbeter, Jihed Chehimi, S. A. Plotkin, Harvey M. Friedman, Samuel R. Abraham and V Fanning and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Stuart E. Starr

140 papers receiving 6.0k citations

Peers

Countries citing papers authored by Stuart E. Starr

Since Specialization

Citations

This map shows the geographic impact of Stuart E. Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart E. Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart E. Starr more than expected).

Fields of papers citing papers by Stuart E. Starr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart E. Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart E. Starr. The network helps show where Stuart E. Starr may publish in the future.

Co-authorship network of co-authors of Stuart E. Starr

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart E. Starr. A scholar is included among the top collaborators of Stuart E. Starr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart E. Starr. Stuart E. Starr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efavirenz liquid formulation in human immunodeficiency virus-infected children 2002 ·The Pediatric Infectious Disease Journal ·Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector, Richard C. Brundage, Florence H. Yong, Steven D. Douglas, Patricia M. Flynn, Mark W. Kline	26
2	Increased Proliferation within T Lymphocyte Subsets of HIV-Infected Adolescents 2002 ·AIDS Research and Human Retroviruses ·Stuart E. Starr, Moussa Sarr, Donald E. Campbell, Craig M. Wilson, Steven D. Douglas	8
3	Respiratory Syncytial Virus: An Association with Severe Asthma Exacerbations in Children of All Ages 2001 ·Pediatric Asthma Allergy & Immunology ·(unknown), Richard L. Hodinka, (unknown), Chris Boardman, Louis M. Bell, Stuart E. Starr, Nicholas A. Pawlowski	5
4	HIV-1 Infection of Placental Cord Blood Monocyte-Derived Dendritic Cells 2001 ·Journal of Hematotherapy & Stem Cell Research ·(unknown), Jeffrey D. Merrill, Yuan Li, Changjiang Guo, Steven D. Douglas, Stuart E. Starr, Wen‐Zhe Ho	3
5	Rapid Method for Determining the Rate of DNA Synthesis and Cellular Proliferation 2000 ·Analytical Biochemistry ·(unknown), (unknown), Stuart E. Starr, Kathleen E. Sullivan, Donald E. Campbell, Steven D. Douglas, Yevgeny Daikhin, (unknown), (unknown), Marc Yudkoff	11
6	Immunizing the HIV-Infected Child 1997 ·AIDS Patient Care and STDs ·Richard M. Rutstein, Stuart E. Starr	2
7	Ganciclovir Treatment of Symptomatic Congenital Cytomegalovirus Infection: Results of a Phase II Study 1997 ·The Journal of Infectious Diseases ·R. J. Whitley, Gretchen A. Cloud, William C. Gruber, Gregory A. Storch, Gail J. Demmler, Richard F. Jacobs, Wayne M. Dankner, Stephen A. Spector, Stuart E. Starr, Robert F. Pass, Sergio Stagno, William J. Britt, Charles A. Alford, (unknown), Xiaojian Zhou, (unknown), (unknown), Jean‐Pierre Sommadossi	219
8	Application of the Polymerase Chain Reaction to the Diagnosis and Management of Neonatal Herpes Simplex Virus Disease 1996 ·The Journal of Infectious Diseases ·David W. Kimberlin, Fred D. Lakeman, Ann M. Arvin, Charles G. Prober, Lawrence Corey, Dwight A. Powell, Sandra Burchett, R. F. Jacobs, Stuart E. Starr, Richard J. Whitley	147
9	Mucosal Antibodies to Human Cytomegalovirus Glycoprotein B Occur following both Natural Infection and Immunization with Human Cytomegalovirus Vaccines 1996 ·The Journal of Infectious Diseases ·Jinbao Wang, S. P. Adler, S. Hempfling, Rae Lyn Burke, (unknown), Stuart E. Starr, S. A. Plotkin	48
10	Impaired interleukin 12 production in human immunodeficiency virus-infected patients. 1994 ·The Journal of Experimental Medicine ·Jihed Chehimi, Stuart E. Starr, Ian Frank, Annalisa D’Andrea, Xiaojing Ma, Rob Roy MacGregor, (unknown), Giorgio Trinchieri	368
11	Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections 1993 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), William C. Gruber, Gregory A. Storch, Gail J. Demmler, Richard A. Jacobs, Wayne M. Dankner, Stuart E. Starr, Robert F. Pass, Sergio Stagno, Charles A. Alford, Seng‐Jaw Soong, Richard J. Whitley, Jean‐Pierre Sommadossi, (unknown)	70
12	Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. 1992 ·The Journal of Experimental Medicine ·Jihed Chehimi, Stuart E. Starr, Ian Frank, Manthrasalam Rengaraju, (unknown), (unknown), Michiko Kobayashi, B Perussia, Deborah Young, Elliot Nickbarg	163
13	Antibody-Dependent Cellular Cytotoxicity (ADCC) Is Directed Against Immunodominant Epitopes of the Envelope Proteins of Human Immunodeficiency Virus 1 (HIV-1) 1992 ·Viral Immunology ·Ulrike Ziegner, Ian Frank, (unknown), Stuart E. Starr, H. -J. Streckert	7
14	Varicella Vaccine Studies in Healthy Children and Adults 1986 ·PEDIATRICS ·Allan M. Arbeter, Stuart E. Starr, Stanley A. Plotkin	154
15	Combination Measles, Mumps, Rubella, and Varicella Vaccine 1986 ·PEDIATRICS ·Allan M. Arbeter, Linda A. Baker, Stuart E. Starr, Bruce L. Levine, (unknown), Stanley A. Plotkin	36
16	Los peores malos 1985 ·PubMed ·Stanley A. Plotkin, (unknown), Stuart E. Starr	5
17	Antimicrobial therapy of bacterial sepsis in the newborn infant 1985 ·The Journal of Pediatrics ·Stuart E. Starr	18
18	The pathogenesis and prevention of human cytomegalovirus infection 1984 ·The Pediatric Infectious Disease Journal ·Stanley A. Plotkin, S. Michelson, Charles A. Alford, Stuart E. Starr, Paul D. Parkman, Joseph S. Pagano, Fred Rapp	7
19	Effects of Interferon on Natural Killing and Antibody-Dependent Cellular Cytotoxicity Against Varicella-Zoster Virus-Infected and Uninfected Target Cells 1983 ·Journal of Interferon Research ·Toshiaki Ihara, Stuart E. Starr, Allan M. Arbeter, Stanley A. Plotkin	7
20	A non-X-linked syndrome with susceptibility to severe epstein-barr virus infections 1982 ·The Journal of Pediatrics ·Gary Fleisher, Stuart E. Starr, (unknown), Hitoshi Kamiya, Steven D. Douglas, Werner Henle	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact